Citadel Advisors »

Context Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $18k 16k 1.13
2023-09-30 $16k 10k 1.51
2022-03-31 $40k 19k 2.15

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Context Therapeutics

Opaleye Management
Vanguard Group
HighTower Advisors
Clear Harbor Asset Management
Susquehanna International
Sheets Smith Wealth Management
Citadel Advisors
UBS Group
Advisor Group Holdings
Retirement Group
Wells Fargo & Company
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Context Therapeutics